|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Ideaya Biosciences, Inc. (IDYA) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
72,130,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile IDEAYA Biosciences is a synthetic lethality-focused precision medicine oncology company engaged in the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Co.'s primary synthetic lethality product candidate is IDE397, a clinical-stage methionine adenosyltransferase 2a inhibitor for patients with solid tumors having methylthioadenosine phosphorylase deletions. Co. is enrolling patients into a Phase 1 clinical trial designated as IDE397-001 to evaluate IDE397. Co. is targeting poly (ADP-ribose) glycohydrolase for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
175,000 |
443,000 |
485,970 |
486,470 |
Total Sell Value |
$7,397,290 |
$18,230,093 |
$19,364,924 |
$19,376,424 |
Total People Sold |
1 |
3 |
4 |
4 |
Total Sell Transactions |
3 |
14 |
28 |
29 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Stone Paul A. |
Chief Financial Officer |
|
2020-06-17 |
4 |
OE |
$4.62 |
$14,322 |
D/D |
3,100 |
18,100 |
|
- |
|
Lackner Mark |
SVP, Head of Biology |
|
2020-06-17 |
4 |
AS |
$19.91 |
$7,428 |
D/D |
(373) |
0 |
|
- |
|
Lackner Mark |
SVP, Head of Biology |
|
2020-06-17 |
4 |
OE |
$4.62 |
$1,723 |
D/D |
373 |
373 |
|
- |
|
Lackner Mark |
SVP, Head of Biology |
|
2020-06-16 |
4 |
AS |
$14.93 |
$100,761 |
D/D |
(6,750) |
0 |
|
- |
|
Lackner Mark |
SVP, Head of Biology |
|
2020-06-16 |
4 |
OE |
$4.62 |
$37,942 |
D/D |
6,750 |
6,750 |
|
- |
|
Throne Jason |
VP, General Counsel |
|
2020-06-04 |
4 |
AS |
$8.66 |
$19,087 |
D/D |
(2,205) |
0 |
|
- |
|
Lackner Mark |
SVP, Head of Biology |
|
2020-06-02 |
4 |
AS |
$8.55 |
$7,779 |
D/D |
(845) |
0 |
|
- |
|
Hata Yujiro S |
President and CEO |
|
2020-04-15 |
4 |
OE |
$4.31 |
$205,001 |
D/D |
47,564 |
658,286 |
|
- |
|
Stone Paul A. |
Chief Financial Officer |
|
2020-03-30 |
4 |
OE |
$4.62 |
$23,100 |
D/D |
5,000 |
15,000 |
|
- |
|
Hata Yujiro S |
President and CEO |
|
2019-07-30 |
4 |
OE |
$4.31 |
$64,650 |
D/D |
15,000 |
610,722 |
|
- |
|
Hager Jeffrey |
SVP, Chief Technology Officer |
|
2019-07-26 |
4 |
OE |
$4.31 |
$22,399 |
D/D |
5,197 |
127,853 |
|
- |
|
Stone Paul A. |
SVP, General Counsel |
|
2019-07-26 |
4 |
OE |
$4.62 |
$46,200 |
D/D |
10,000 |
10,000 |
|
- |
|
Hager Jeffrey |
SVP, Chief Technology Officer |
|
2019-07-10 |
4 |
OE |
$4.31 |
$30,795 |
D/D |
7,145 |
122,656 |
|
- |
|
Hager Jeffrey |
SVP, Chief Technology Officer |
|
2019-06-19 |
4 |
OE |
$4.31 |
$37,187 |
D/D |
8,628 |
115,511 |
|
- |
|
Alexandria Venture Investments, Llc |
10% Owner |
|
2019-05-28 |
4 |
B |
$10.00 |
$500,000 |
D/D |
50,000 |
432,384 |
2.45 |
- |
|
Alexandria Venture Investments, Llc |
10% Owner |
|
2019-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
382,384 |
382,384 |
|
- |
|
Canaan Partners X Llc |
10% Owner |
|
2019-05-28 |
4 |
B |
$10.00 |
$4,000,000 |
D/D |
400,000 |
2,660,713 |
2.45 |
- |
|
Canaan Partners X Llc |
10% Owner |
|
2019-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,260,713 |
2,260,713 |
|
- |
|
Shannon Timothy M |
Director |
|
2019-05-28 |
4 |
B |
$10.00 |
$4,000,000 |
I/I |
400,000 |
2,660,713 |
2.1 |
- |
|
Shannon Timothy M |
Director |
|
2019-05-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,260,713 |
2,260,713 |
|
- |
|
Diekman John D |
Director |
|
2019-05-28 |
4 |
B |
$10.00 |
$2,500,000 |
I/I |
250,000 |
118,521 |
2.1 |
- |
|
Diekman John D |
Director |
|
2019-05-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,396,191 |
108,521 |
|
- |
|
Stone Paul A. |
SVP, General Counsel |
|
2019-05-28 |
4 |
B |
$10.00 |
$2,500,000 |
I/I |
250,000 |
118,521 |
1.99 |
- |
|
Stone Paul A. |
SVP, General Counsel |
|
2019-05-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,396,191 |
108,521 |
|
- |
|
Schwab Andrew J. |
10% Owner |
|
2019-05-28 |
4 |
B |
$10.00 |
$7,500,000 |
I/I |
750,000 |
500,000 |
1.5 |
- |
|
135 Records found
|
|
Page 5 of 6 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|